Saturday, March 28, 2026 • 09:18 AM
  • Home
  • /
  • News
  • /
  • Leading a Landmark Charge to Make Affordability an Integral Part of Any Healthcare Journey
Pharmacy Management
News

Leading a Landmark Charge to Make Affordability an Integral Part of Any Healthcare Journey

Doceree, the world’s first global network for programmatic HCP engagement, has officially announced the launch of its co-pay.com solution, which happens to be the largest and most comprehensive database made up with co-pay and patient affordability programs.

According to certain reports, the stated database arrives on the scene as integrated within physician workflows so to deliver real-time, patient-specific co-pay support, enabling better access and adherence.

To understand the significance of such a development, we must take into account how high out-of-pocket medication costs remain one of the biggest barriers to adherence. You see, co-pay and affordability programs do exist in abundance, but having said so, they continue to go underutilized. This happens to be the case because they simply don’t reach patients when and where they need them most.

Against that, Doceree makes it possible for pharma manufacturers to deliver affordability messaging directly to healthcare professionals (HCPs), right within their workflows.

“Cost shouldn’t stop patients from starting or staying on therapy,” said Harshit Jain, MD, Founder & Global CEO of Doceree. “co-pay.com puts actionable affordability tools in the hands of HCPs, empowering them to support patients in real time and improve outcomes. After all, affordability shouldn’t be an afterthought—it should be part of the clinical conversation.”

Talk about the whole value proposition on a slightly deeper level, we begin from the fact that Doceree’s latest brainchild leverages its robust point-of-care (POC) network and patented platform to conceive AI-powered nudges. 

This translates to how the technology conceives contextually relevant, patient-personalized affordability messages based on real-time clinical actions, thus ensuring support is surfaced precisely when it matters most.

Next up, we have Real-Time Benefit Checks (RTBC) coming into play. These checks are tasked with instantly displaying patient-specific prescription costs, coverage options, and available co-pay support, each component coming in handy to help HCPs make informed decisions during the prescribing process.

Now, we must expand the solution’s EHR Integration. You see, at launch, co-pay.com is compatible with over 150 EHR platforms, including Epic and Cerner. As a result, it requires no setup fees or technical integration from pharma manufacturers, something which eventually powers frictionless scalability.

Another detail worth a mention relates to the availability of multi-format co-pay distribution. Leveraging the given facility, HCPs can seamlessly share co-pay offers via text, email, patient portals, printed handouts, or directly through e-prescriptions to pharmacies. Such a mechanism treads up a long distance to unlock accessibility across patient touchpoints.

Hold on, we still have a couple of bits left to unpack, considering we haven’t yet touched upon the underlying technology’s compliance-first architecture, which runs atop the highest standards of healthcare data privacy. We get to say so because Doceree’s solution is fully HIPAA, GDPR, and PHI compliant.

Rounding up highlights would be the prospect of flexible and scalable pricing. For better understanding, co-pay.com employs a pay-as-you-go model that allows manufacturers to quickly onboard, scale their programs, as well as access prescriber-level insights and engagement analytics to optimize performance.

Founded in 2020, Doceree’s rise up the ranks stems from its patented technology, which is geared towards scaling up HCP- patient conversations and interactions so to ensure they are intrinsically more meaningful, richer, and outcome oriented. The company’s excellence in what it does can also be understood once you consider it is currently operational in more than 22 different markets.

“We like the fact that Doceree offers omni-channel orchestration and automation. We know that Doceree, unlike other aggregators, offers direct and fully integrated platform technology that enables faster and more granular reporting,” said VP of a company.

  • By Editorial Panel
  • 08 May 2025
Share Post:

Latest News

News Image
Drug Discovery and Development

Deep Intelligent Pharma Raises...

By Editorial Panel, Pharma Busine...

News Image
Pharmacy Management

When Winter Viruses Rise, Huma...

By Editorial Panel, Pharma Busine...

News Image
Drug Discovery and Development

Axol Bioscience Secures $2.8M...

By Editorial Panel, Pharma Busine...

News Image
Pharmacy Management

Conceiving a Unique Biological...

By Editorial Panel, Pharma Busine...

News Image
Clinical Trial Management

Conceiving a Doorway to Enhanc...

By Editorial Panel, Pharma Busine...

Pharma Business Outlook

Pharma Business Outlook is more than just a publication—it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem.